FeesSafety
Pluang+

Irvine Spectrum Center unveils new 132-foot Spectrum SunWheel with enhanced features and views

Others
17 Sep 2026
PRNewsWire
View Source
Neutral
Irvine Spectrum Center unveils new 132-foot Spectrum SunWheel with enhanced features and views

Irvine Spectrum Center in Southern California has opened the new Spectrum SunWheel, a 132-foot tall observation wheel that replaces the previous Giant Wheel. Manufactured by Italy's Fabbri Group, the SunWheel offers 27 gondolas with improved audio, LED lighting, and faster ride operations, providing visitors stunning views and a modernized experience. The grand opening event includes live music and free rides for the first 300 guests. This attraction aims to enhance the center's appeal as a premier shopping and entertainment destination.

The Spectrum SunWheel debut at Irvine Spectrum Center offers context for consumer cyclical stocks. For readers following this sector, here is Pluang's market snapshot as of Sep 17, 2026 21:16 WIB: Out of 105 priced US stocks, 71 rose and 33 fell. Notable movers include LCID at USD 4.48 with a +10.89% change and 100% buy order activity, QS at USD 5.24 with a +4.70% change and 97% sell order activity, and RIVN at USD 15.94 with a +4.66% change and 100% buy order activity.

More News

Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...

Company Fundamentals
Bullish
46 minutes ago
Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...

Company Fundamentals
Bullish
46 minutes ago
Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...

Market News
Bullish
46 minutes ago
eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...

Others
Neutral
1 hour ago
Balchem posts Q3 2026 sales of $290.7M, net earnings up 16%, driven by growth in all segments.

Balchem posts Q3 2026 sales of $290.7M, net earnings up 16%, driven by growth in all segments.

Balchem Corporation reported strong Q3 2026 results with net sales of $290.7 million, up 8.6% year-over-year, and net earnings of $46.7 million, a 16% increase. Growth was driven by all three segments: Human Nutrition and Health, Animal Nutrition and...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App